Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 22;17(12):e0279290.
doi: 10.1371/journal.pone.0279290. eCollection 2022.

Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma

Affiliations

Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma

Yuqi Cai et al. PLoS One. .

Abstract

Objective: This study examined the reliability and validity of a Shame and Stigma Scale (SSS) and assessed shame and stigma among patients with facial disfigurement from nasopharyngeal carcinoma (NPC).

Methods: Data were collected from 218 patients with NPC through a cross-sectional survey between January 14, 2020, and December 1, 2020. The original SSS is a 20-item scale with four dimensions (i.e., shame with appearance, sense of stigma, regret, and social/speech concern). We used Cronbach's alpha and McDonald's omega to assess reliability and exploratory factor analysis (EFA) to assess the factor structure. We also used Pearson correlation analysis to examine the relationship between each item and total score of scale items and convergent validity.

Results: The final 18-item SSS had a Cronbach's alpha coefficient of .89. The EFA revealed that the SSS has a four-factor structure: sense of stigma, social/speech concern, shame with appearance, and regret. These factors showed satisfactory reliability, with McDonald's omega coefficients of .87, .77, .86, and .79, respectively. The scale showed significant relationship between each item and total score of scale items with respect to item-total correlations, item-subscale correlations, and item-other-subscale correlations. Convergent validity was supported by the significant positively correlated with the total scores for depression and anxiety.

Conclusion: The SSS is valid and reliable in assessing shame and stigma and monitoring treatment compliance among patients with NPC.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Chen Y, Chen W, Yang Y, Zhao Y, Yang X. Characteristics of symptom distress in Chinese nasopharyngeal carcinoma patients and its relation to mood disturbance: A cross-sectional study. European journal of cancer care. 2019;28(4):e13032. doi: 10.1111/ecc.13032 - DOI - PubMed
    1. Li R, Su L, Hua Y, Ye JR, Song XR, Tian J, et al.. Anxiety and depression status prior to radiotherapy in patients with nasopharyngeal carcinoma and its effect on acute radiation toxicities. European journal of cancer care. 2021;30(6):e13487. doi: 10.1111/ecc.13487 - DOI - PubMed
    1. WHO. Depression and Other Common Mental Disorders: Global Health Estimates 2017. Available from: https://www.who.int/publications/i/item/depression-global-health-estimates.
    1. McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al.. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. International journal of radiation oncology, biology, physics. 2018;102(2):340–52. doi: 10.1016/j.ijrobp.2018.05.060 - DOI - PubMed
    1. Cho J, Choi EK, Kim SY, Shin DW, Cho BL, Kim CH, et al.. Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. Psycho-oncology. 2013;22(10):2372–8. doi: 10.1002/pon.3302 - DOI - PubMed

Publication types

Grants and funding

This research was funded by the Sun Yat-Sen University Young Teacher Incubation Foundation of China, grant number Ref#20ykpy84. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.